How BSA Is Used for Chemotherapy Dosing

July 14, 2026

Why Chemotherapy Uses BSA Instead of Weight Alone

Most chemotherapy drugs are dosed using body surface area rather than a flat dose or weight-based (mg/kg) dosing. The FDA’s labeling guidance for weight- or BSA-based dosing reflects this long-standing convention across many cytotoxic drug labels. BSA-based dosing exists because, for many drugs, BSA correlates more closely with metabolic rate, cardiac output, and drug clearance than body weight alone — meaning it more consistently predicts how a patient’s body will process and clear the drug. This guide explains the mechanics; it is educational reference only, not a substitute for prescriber-calculated dosing.

The mg/m² Convention

Chemotherapy drug labels typically specify a dose in mg per square meter of BSA — for example, “175 mg/m².” The total dose administered is that figure multiplied by the patient’s calculated BSA:

Total Dose = Dose per m² × Patient BSA (m²)

Example: A drug dosed at 175 mg/m², given to a patient with a calculated BSA of 1.82 m²:

175 × 1.82 = 318.5 mg

This is exactly the reference calculation the BSA calculator’s optional dose field performs, using the Mosteller BSA value — for educational reference only.

Which BSA Formula Do Oncologists Actually Use?

Mosteller is the most common default at institutions today because of its simplicity and strong clinical validation, though DuBois & DuBois remains an accepted alternative at many sites, provided it doesn’t produce more than roughly a 10% dosing difference from Mosteller for the same patient. The specific formula an institution uses is a protocol decision, not something a patient or caregiver should assume — always confirm with the prescribing oncology team which formula and rounding convention their institution follows.

What Is BSA Capping?

Some institutions cap the BSA value used for dosing calculations at a fixed ceiling — commonly 2.0 or 2.2 m² — even for patients whose actual calculated BSA is higher. The reasoning is that above a certain body size, further dose scaling risks disproportionate toxicity without a corresponding benefit. However, research published via the NIH’s PubMed Central archive has found that BSA capping doesn’t uniformly improve safety outcomes across all cytotoxic drugs, meaning the practice varies by drug, protocol, and institution rather than being a universal standard.

Why Formula Choice Matters More at Larger and Smaller Body Sizes

The three major BSA formulas — Mosteller, DuBois, and Haycock — agree closely (within about 1%) for typical adult proportions, but diverge more at the extremes of body size. For a patient near an institution’s BSA capping threshold, the choice of formula could plausibly shift whether a calculated BSA lands just above or just below the cap. See BSA worked examples for how much the formulas actually diverge across different body sizes.

This Is a Reference Tool, Not a Prescribing Authority

BSA-based chemotherapy dosing carries real safety implications, and a dosing calculation error can be serious. The BSA calculator is intended to help patients, caregivers, and students understand how the calculation works — any actual medication dose must be calculated, verified, and prescribed by a qualified oncology provider following their institution’s specific protocol, never derived solely from an online calculator. See common BSA calculation mistakes for the errors that most often affect BSA results.